Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders

A Newman-Tancredi, RY Depoortère… - Pharmacology & …, 2022 - Elsevier
Biased agonism (or “functional selectivity”) at G-protein-coupled receptors has attracted
rapidly increasing interest as a means to improve discovery of more efficacious and safer …

Serotonin transporter in Parkinson's disease: A meta‐analysis of positron emission tomography studies

G Pagano, F Niccolini, P Fusar‐Poli… - Annals of …, 2017 - Wiley Online Library
Positron emission tomography (PET) is a powerful analytical tool for in vivo molecular
imaging of the human brain. Over the past years, a number of PET studies imaging the …

Intermittent fasting protects against the deterioration of cognitive function, energy metabolism and dyslipidemia in Alzheimer's disease-induced estrogen deficient rats

BK Shin, S Kang, DS Kim… - Experimental biology and …, 2018 - journals.sagepub.com
Intermittent fasting may be an effective intervention to protect against age-related metabolic
disturbances, although it is still controversial. Here, we investigated the effect of intermittent …

Hypericum perforatum extract attenuates behavioral, biochemical, and neurochemical abnormalities in aluminum chloride-induced Alzheimer's disease rats

Z Cao, F Wang, C Xiu, J Zhang, Y Li - Biomedicine & pharmacotherapy, 2017 - Elsevier
Alzheimer's disease (AD) is a progressive and ultimately fatal neurodegenerative diseases.
Aluminum, a neurotoxic metal, is considered as the pathological hallmark and contributing …

Understanding how physical exercise improves Alzheimer's disease: cholinergic and monoaminergic systems

B Zong, F Yu, X Zhang, W Zhao, P Sun… - Frontiers in Aging …, 2022 - frontiersin.org
Alzheimer's disease (AD) is an age-related neurodegenerative disorder, characterized by
the accumulation of proteinaceous aggregates and neurofibrillary lesions composed of β …

In silico, in vitro, and in vivo evaluation of new candidates for α-synuclein PET imaging

M Verdurand, E Levigoureux, W Zeinyeh… - Molecular …, 2018 - ACS Publications
Accumulation of α-synuclein (α-syn) is a neuropathological hallmark of synucleinopathies.
To date, no selective α-syn positron emission tomography (PET) radiotracer has been …

Learning from amyloid trials in Alzheimer's disease. A virtual patient analysis using a quantitative systems pharmacology approach

H Geerts, A Spiros - Alzheimer's & Dementia, 2020 - Wiley Online Library
Background Many trials of amyloid‐modulating agents fail to improve cognitive outcome in
Alzheimer's disease despite substantial reduction of amyloid β levels. Methods We applied a …

Impact of amyloid-beta changes on cognitive outcomes in Alzheimer's disease: analysis of clinical trials using a quantitative systems pharmacology model

H Geerts, A Spiros, P Roberts - Alzheimer's research & therapy, 2018 - Springer
Background Despite a tremendous amount of information on the role of amyloid in
Alzheimer's disease (AD), almost all clinical trials testing this hypothesis have failed to …

Hippocampal 5-HT1A receptor expression changes in prodromal stages of Alzheimer's disease: Beneficial or deleterious?

M Verdurand, L Zimmer - Neuropharmacology, 2017 - Elsevier
There is increasing evidence that the serotonergic system is highly dysfunctional in
Alzheimer's disease (AD), and this could be related to cognitive impairments associated with …

Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: a post-mortem study with PET radiopharmaceuticals

B Vidal, J Sebti, M Verdurand, S Fieux, T Billard… - …, 2016 - Elsevier
PET imaging studies using 5-HT 1A receptor radiotracers show a decreased density of this
receptor in hippocampi of patients with Alzheimer's disease (AD) at advanced stages …